Dr. Paul Adams joins La Jolla Pharmaceutical advisory board

La Jolla Pharmaceutical Company has named four physicians to its LJPC-401 advisory board, including gastroenterologist Paul Adams, MD.  

Advertisement

The LJPC-401 advisory board focuses on the company’s development of hepcidin. Dr. Adams is a professor of medicine and chief of gastroenterology at the University of Western Ontario in London, Ontario. The company also added:

•    Victor Gordeuk, MD
•    Ashutosh Lal, MD
•    Gordon McLaren, MD

More articles on gastroenterology:
Mutare Health names Dr. Lawrence Kosinski CMO
Ritter Pharmaceuticals names Gerald Proehl to board of directors
PPI therapy may increase risk of kidney injury in elderly

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.